Sally Turner - Sotera Health Chief Officer
| SHC Stock | USD 13.10 0.15 1.16% |
Insider
Sally Turner is Chief Officer of Sotera Health Co
| Address | 9100 South Hills Boulevard, Broadview Heights, OH, United States, 44147 |
| Phone | 440 262 1410 |
| Web | https://soterahealth.com |
Sotera Health Management Efficiency
The company has Return on Asset of 0.0768 % which means that on every $100 spent on assets, it made $0.0768 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.167 %, implying that it generated $0.167 on every 100 dollars invested. Sotera Health's management efficiency ratios could be used to measure how well Sotera Health manages its routine affairs as well as how well it operates its assets and liabilities. At present, Sotera Health's Return On Assets are projected to increase slightly based on the last few years of reporting. The current year's Return On Equity is expected to grow to 0.12, whereas Return On Capital Employed is forecasted to decline to 0.06. At present, Sotera Health's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Assets is expected to grow to about 3.1 B, whereas Net Tangible Assets are forecasted to decline to (1.2 B).Similar Executives
| Showing other executives | INSIDER Age | ||
| Ruth VilligerWilson | RadNet Inc | 60 | |
| Yusheng Han | Burning Rock Biotech | 45 | |
| John Boniface | Sera Prognostics | 62 | |
| Dr MBA | ICON PLC | 64 | |
| Thomas OLeary | ICON PLC | N/A | |
| Steven Graves | Sera Prognostics | N/A | |
| Paul Kearney | Sera Prognostics | 56 | |
| Ryan Douglas | Exagen Inc | N/A | |
| Natalie Munk | Myriad Genetics | 43 | |
| Nadia Altomare | Sera Prognostics | 53 | |
| Dale Muzzey | Myriad Genetics | 44 | |
| Clivetty Martinez | Myriad Genetics | N/A | |
| Dana Snr | ICON PLC | N/A | |
| Zhihong Zhang | Burning Rock Biotech | 48 | |
| Paul Changelian | Aclaris Therapeutics | N/A | |
| Douglas Jones | Neogen | 54 | |
| Trudy Stein | IQVIA Holdings | N/A | |
| Mark Hazeltine | Exagen Inc | 50 | |
| Michael MD | Sera Prognostics | N/A | |
| Robert Doody | Aclaris Therapeutics | N/A | |
| Brandon Ebken | Medpace Holdings | N/A | |
Management Performance
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.0768 |
Sotera Health Leadership Team
Elected by the shareholders, the Sotera Health's board of directors comprises two types of representatives: Sotera Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sotera. The board's role is to monitor Sotera Health's management team and ensure that shareholders' interests are well served. Sotera Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sotera Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Hauzie, Chief Officer | ||
| Lehmann JD, Sr Devel | ||
| Joseph Vitale, Vice Relations | ||
| Riaz MBA, President Nordion | ||
| Michael Biehl, Interim Officer | ||
| Michael Petras, Chairman CEO | ||
| Michael Rutz, President Sterigenics | ||
| Kristin Gibbs, Chief Officer | ||
| Sally Turner, Chief Officer | ||
| Alexander Dimitrief, Sr Counsel | ||
| Joseph Shrawder, President Labs | ||
| Jason Peterson, VP Treasurer | ||
| Kevin Theriault, VP Operations | ||
| Kathleen Hoffman, Health Environmental | ||
| Jonathan Lyons, Senior CFO | ||
| Danielle Menture, Health Environmental | ||
| Alexander JD, General VP |
Sotera Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sotera Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.0768 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.32 % | ||||
| Current Valuation | 5.76 B | ||||
| Shares Outstanding | 283.24 M | ||||
| Shares Owned By Insiders | 2.46 % | ||||
| Shares Owned By Institutions | 94.62 % | ||||
| Number Of Shares Shorted | 8.69 M | ||||
| Price To Earning | 61.32 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sotera Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sotera Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sotera Health Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sotera Health Co Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sotera Health Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sotera Health. If investors know Sotera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sotera Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.62) | Earnings Share 0.25 | Revenue Per Share 3.969 | Quarterly Revenue Growth 0.085 | Return On Assets 0.0768 |
The market value of Sotera Health is measured differently than its book value, which is the value of Sotera that is recorded on the company's balance sheet. Investors also form their own opinion of Sotera Health's value that differs from its market value or its book value, called intrinsic value, which is Sotera Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sotera Health's market value can be influenced by many factors that don't directly affect Sotera Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sotera Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sotera Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sotera Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.